Granisetron hydroch...

Granisetron hydrochloride

Granisetron hydrochloride

Min.Order / FOB Price:Get Latest Price

1 Kilogram

Negotiable

  • Min.Order :1 Kilogram
  • Purity: 98%
  • Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Granisetron hydrochloride 107007-99-8 manufacturer , better price with good quality

Quick Details

  • Appearance:White to Off-White Crystalline Sold
  • Application: Pharmaceuticals
  • PackAge:Depended
  • ProductionCapacity:300|Kilogram|Month
  • Storage:KEEP COLD
  • Transportation:BY SEA OR AIR

Superiority:


Preview
CBNumber: CB9728851
Chemical Name: Granisetron hydrochloride
Molecular Formula: C18H25ClN4O
Formula Weight: 348.87
CAS No.: 107007-99-8
Granisetron hydrochloride Basic information
Outline of Granisetron hydrochloride Domestic Market Analysis Instructions Chemical Properties Application
Product Name: Granisetron hydrochloride
Synonyms: 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxamid;endo-1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxa;endo-monohydrochlorid;midehydrochloride;1-METHYL-N-[(3-ENDO)-9-METHYL-9-AZABICYCLO[3.3.1]NON-3-YL]-1H-INDAZOLE-3-CARBOXAMIDE HYDROCHLORIDE;KYTRIL;BRL-43694A;GRANISERTROL HYDROCHLORIDE
CAS: 107007-99-8
MF: C18H25ClN4O
MW: 348.87
EINECS:  
Product Categories: Pharmaceutical material and intermeidates;Active Pharmaceutical Ingredients;API;Heterocyclic Compounds;Intermediates & Fine Chemicals;Neurochemicals;Pharmaceuticals;Granisetron;Serotonin receptor;Serotonin;Heterocycles;SINTROM;Other APIs;Digestive System
Mol File: 107007-99-8.mol
Granisetron hydrochloride Structure
 
Granisetron hydrochloride Chemical Properties
mp  290-292°C
storage temp.  Room temp
CAS DataBase Reference 107007-99-8(CAS DataBase Reference)
 
Safety Information
Hazard Codes  Xn,Xi
Risk Statements  22-62-37/38-36/37/38-36
Safety Statements  26-36-37
RTECS  NK7882200
MSDS Information
 
 
Granisetron hydrochloride Usage And Synthesis
Outline of Granisetron hydrochloride Granisetron hydrochloride was originally developed by the British Beecham company in the mid-1980s. At 1991, the merged Smithkline-Beecham (SB) Company had pushed for the first time of 3 mg of injection Kytri1 to the market in South Africa. To date, including 1 mg of oral tablets, 1mg of injections, granisetron hydrochloride has already entered into market in United States, Britain, France, Japan, Germany, Italy and other more than forty countries and regions around the world. When the Smithkline-Beecham (SB) Company was merged with Glaxo Company, it transferred this product to the Roche Company. 
Foreign research data has shown that granisetron hydrochloride has a high selectivity to receptor. Its affinity to 5-HT3 receptor is 4000 to 10000 time as high as its affinity to other receptors, such as 5-HT1, 5-HT2, dopamine D1, D1, histamine H1, benzodiazepine and opioid receptor. For comparison, the difference for ondansetron is only about 1,000 times. For the test of its prevention of cisplatin-induced emesis in ferrets, the antiemetic rates in the three dose groups of granisetron hydrochloride 2 × 0.005,2 × 0.05 and 2 × 0.5mg / kg (iv) were 93%, 96% and 100 %, respectively while for ondansetron in 2 × 2.5mg / kg, this value was 89%, demonstrating that granisetron hydrochloride exhibited a at least five times stronger efficacy of anti-emetic than ondansetron. Toxicity studies suggest that granisetron hydrochloride can achieve very excellent antiemetic effect even in small dose with only minor side effects. However, there may be sth abnormal occurring in cardiovascular system upon large doses. Since the recommended clinical dose of granisetron hydrochloride is small (3mg / d), which is only 1/25 (<1 mg/kg) of the lowest dose used in animal studies, therefore, clinical application of it is very safe. Pharmacokinetic study has shown that granisetron hydrochloride has a half-life (t1/2) of 9 h in the body of patient while this value is 4 h at healthy people, 7.7 h in elderly people and 4.9h in young people. Granisetron hydrochloride is mainly metabolized in the liver and can be excreted through the feces and urine in the form of 7-hydroxy granisetron hydrochloride and other forms of metabolic product. For patients of liver damage or liver metastases, they have reduced plasma clearance rate with the scavenging rate upon renal insufficiency being 1/4 of the normal case. It has been observed of high first pass metabolism upon oral administration with the absolute bioavailability being 60%.
Domestic Market Analysis 1993, China has approved of the import of the Kytri1 injection (3 mg/ 3 mL) of British SB company, Registration No: X930279, and has allowed for in clinical trials. In 1994, the China-US Tianjin Smith Kline Pharmaceutical Co., Ltd. had used imported raw materials processing method for production of the injection of the 3mg granisetron hydrochloride and had obtained the approval of the Ministry of Health: (94) health medicine approved: J-10 number (fourth class) with the trade name being "Kay Reiter. " Currently there are a number of domestic manufacturers having their products enter into market with the number of manufacture which makes formulation being up to dozen, see Annex I for details. 
China has a large population with the annual number of newly identified cancer patients being more than 1.6 million. The nausea and vomiting induced by chemotherapy and radiotherapy-induced have been one of the serious side effects that doctors and patients worry of. Therefore, new antiemetics are in urgent demand. Currently, ondansetron class of drugs has occupied most of the market antiemetic including ondansetron (ShufuLing), granisetron hydrochloride (Kytril) and tropisetron (Oubiting), wherein the ondansetron and granisetron has been accumulated of large number of clinical application experience with good response from the doctors and has played positive role on improving the domestic situation of the treatment of chemotherapy vomiting. With the localization of products, the decreasing price and the increasing income level of people, antiemetics market will be certainly greatly improved. In this case, granisetron hydrochloride, as the secondary antiemetic drug entering into market, will certainly have good market prospects.
The above information is edited by the chemicalbook of Dai Xiongfeng.
Instructions [Character]it is colorless or nearly colorless liquid clarity. 
[Toxicology]This product is a highly selective 5-HT3 receptor antagonist and has excellent preventive and therapeutic effect on treating nausea and vomiting induced by radiotherapy, chemotherapy and surgery. Radiotherapy, chemotherapy and surgery and other factors can cause enterochromaffin cells to release 5-HT; 5-HT can activate the 5-HT3 receptors in central nerve or vagus nerve and cause vomiting reflex. The mechanism of this product in controlling nausea and vomiting is through antagonizing the 5-HT3 receptor in the central chemosensory area and peripheral vagus nerve terminal, further suppressing the nausea and vomiting. This product has high selectivity and no side effects such as extrapyramidal reactions, excessive sedation and so on.
[Indications]it is suitable for the treatment of nausea and vomiting induced by radiation therapy and cytotoxic drug.
[Dosage and usage amount]intravenous drip. Recommended dosage for adults is usually 3 mg. Administer it intravenously 30 minutes prior to chemotherapy. Most patients only need to be administered once with the prevention action against nausea and vomiting being more than 24 hours. The number of doses can be increased by 1-2 times if necessary, but the maximum daily dose should not exceed 9 mg and the infusion time should not be less than 5 minutes.
[Pharmacokinetics]healthy volunteers, after intravenous injection of this product for 20 or 40 μg/kg, the average peak plasma concentration was 13.7 and 42.8μg / L, the plasma elimination half-life is approximately 3.1-5.9 hours. This product is widely distributed in the body with serum protein binding rate being about 65%. Most of them are rapidly metabolized with the major metabolic pathway being N-dealkylation and conjugation after aromatic oxidation. This product is excreted through the feces and urine.
Chemical Properties It is white or yellowish white crystalline powder and is odorless. It is easily soluble in water but hardly soluble in methanol, extremely hardly to be dissolved in ethanol and almost insoluble in ether. It has a melting point of 290-292 ℃. For acute toxicity LD50, female mice, male and female rats (mg / kg): 17, 25, 14, 16, respectively. Intravenous injection.
Application It is the selective antagonist of the 5-serotonin 3 (5-HT3) in peripheral and central nervous system.
Chemical Properties White to Off-White Crystalline Sold
Usage anticoagulant
Usage A specific serotonin (5HT3) receptor antagonist. Used as an antiemetic. Granisetron HCl is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemothera py. Its main effect is to reduce the activity of the vagus nerve. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarini c receptor
Biological Activity 5-HT 3 receptor antagonist that possesses potent antiemetic activity.
 
Granisetron hydrochloride Preparation Products And Raw materials
Raw materials Hydrochloric acid-->Granisetron

 

Details:

Henan Sunlake Enterprise Corporation is located in Henan Province, the central plain of China , Which enjoys favorable geogeaphical position and convenient transportion. The comany was established in june 1998 , until now having more than 18 years experience in manufacturing & exporting chemical raw material .
     Sunlake is a professional manufacturer engaged in producing and selling chemicals,including Organic & inorganic chemicals , pigments & Dyestuffs ,  Water treatment chemicals , Food & FEED additives and others . These products have been being well exported to Europe , Southeast Asia , the Middle East ,  Africa , South America and some other countries and areas.
    We sincerely welcome foreign friends to visit our plant for cooperation. With the idea of "quality first,credit priority, Excellent service", We are highly acknowledged by customers for good quality and competitive price. More importantly , the company has a strong R & D team who are professional engineers and scholars with Ph. D. .So we are confident to serve you  better with our high - quality products and professional team.
    We are taking great efforts to provide our customers with demanded goods and professional services, continuously improve our core ability of competition and get the momentum for sustainable development ,Which finally makes us being a reliable and professional supplier in international market.
     We welcome any inquiries from all customers of the world, and sincerely hope to cooperate with you for a brilliant future!
 
Our Advantages:
I). We have abundant professional production experience.
II). We have our own chemical factory.
III). Sample is free of charge.
IV). Reasonable Price, Excellent Quality & Attentive Service
V). Prompt reply: we can reply your inquiry and email within 24 hours.
VI). Fast Delivery: The delivery time is about 10-20 days after receiving the deposit.
VII). We have passed the LFGB, SGS, STC, HSL and some other tests.
VIII). We have a unity cooperation team.
 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View